FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166794562> ?p ?o ?g. }

• W3166794562 abstract "Clinical evidence has shown that few non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations can benefit from immunotherapy. The tumor immune microenvironment (TIME) is a significant factor affecting the efficacy of immunotherapy. However, the TIME transformational process in EGFR-mutation patients is unknown.The mRNA expression and mutation data and lung adenocarcinoma (LUAD) clinical data were obtained from The Cancer Genome Atlas (TCGA) database. Profiles describing the immune landscape of patients with EGFR mutations were characterized by differences in tumor mutation burden (TMB), ESTIMATE, CIBERSORT, and microenvironment cell populations-counter (MCP-counter).In total, the TCGA data for 585 patients were analyzed. Among these patients, 98 had EGFR mutations. The TMB was lower in the EGFR group (3.94 mut/Mb) than in the KRAS mutation group (6.09 mut/Mb, P < 0.001) and the entire LUAD (6.58 mut/Mb, P < 0.001). The EGFR group had a lower population of activated immune cells and an even higher score of immunosuppressive cells. A further inter-group comparison showed that differences in the TMB and tumor-infiltrating lymphocytes were only found between patients with oncogenic mutations and unknown mutation. Meanwhile, there were more myeloid dendritic cells (DCs) in EGFR 19del than in L858R-mutation patients and in common mutation patents than in uncommon mutation patients (P < 0.05). Additionally, we established a D score, where D = MCP-counter score for cytotoxic T lymphocytes (CTLs)/MCP-counter score for myeloid DCs. Further analysis revealed that lower D scores indicated immune suppression and were negatively related to several immunotherapy biomarkers.The TIME of EGFR mutant NSCLC was immunosuppressive. Myeloid DCs gradually increased in EGFR 19del, L858R, and uncommon mutations. The potential role of CTLs and DCs in the TIME of patients requires further investigation." @default.
• W3166794562 created "2021-06-22" @default.
• W3166794562 creator A5004150390 @default.
• W3166794562 creator A5008296560 @default.
• W3166794562 creator A5020974117 @default.
• W3166794562 creator A5026350219 @default.
• W3166794562 creator A5030376299 @default.
• W3166794562 creator A5047938453 @default.
• W3166794562 creator A5068920157 @default.
• W3166794562 creator A5083246816 @default.
• W3166794562 date "2021-05-31" @default.
• W3166794562 modified "2023-09-29" @default.
• W3166794562 title "Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma" @default.
• W3166794562 cites W1967394241 @default.
• W3166794562 cites W2096198395 @default.
• W3166794562 cites W2130430382 @default.
• W3166794562 cites W2533508881 @default.
• W3166794562 cites W2587048937 @default.
• W3166794562 cites W2607954371 @default.
• W3166794562 cites W2766425839 @default.
• W3166794562 cites W2777461561 @default.
• W3166794562 cites W2788142646 @default.
• W3166794562 cites W2796207838 @default.
• W3166794562 cites W2797675588 @default.
• W3166794562 cites W2798055402 @default.
• W3166794562 cites W2805354595 @default.
• W3166794562 cites W2912107322 @default.
• W3166794562 cites W2912418732 @default.
• W3166794562 cites W2937223370 @default.
• W3166794562 cites W2938898812 @default.
• W3166794562 cites W2946166987 @default.
• W3166794562 cites W2953757801 @default.
• W3166794562 cites W2968200811 @default.
• W3166794562 cites W2970536272 @default.
• W3166794562 cites W2975736787 @default.
• W3166794562 cites W3000009976 @default.
• W3166794562 cites W3000445801 @default.
• W3166794562 cites W3014748351 @default.
• W3166794562 cites W3024847839 @default.
• W3166794562 cites W3028153189 @default.
• W3166794562 cites W3082530149 @default.
• W3166794562 cites W3088005314 @default.
• W3166794562 cites W3123838577 @default.
• W3166794562 cites W3128646645 @default.
• W3166794562 doi "https://doi.org/10.3389/fonc.2021.591922" @default.
• W3166794562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8200668" @default.
• W3166794562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34136375" @default.
• W3166794562 hasPublicationYear "2021" @default.
• W3166794562 type Work @default.
• W3166794562 sameAs 3166794562 @default.
• W3166794562 citedByCount "8" @default.
• W3166794562 countsByYear W31667945622021 @default.
• W3166794562 countsByYear W31667945622022 @default.
• W3166794562 countsByYear W31667945622023 @default.
• W3166794562 crossrefType "journal-article" @default.
• W3166794562 hasAuthorship W3166794562A5004150390 @default.
• W3166794562 hasAuthorship W3166794562A5008296560 @default.
• W3166794562 hasAuthorship W3166794562A5020974117 @default.
• W3166794562 hasAuthorship W3166794562A5026350219 @default.
• W3166794562 hasAuthorship W3166794562A5030376299 @default.
• W3166794562 hasAuthorship W3166794562A5047938453 @default.
• W3166794562 hasAuthorship W3166794562A5068920157 @default.
• W3166794562 hasAuthorship W3166794562A5083246816 @default.
• W3166794562 hasBestOaLocation W31667945621 @default.
• W3166794562 hasConcept C104317684 @default.
• W3166794562 hasConcept C121608353 @default.
• W3166794562 hasConcept C126322002 @default.
• W3166794562 hasConcept C143998085 @default.
• W3166794562 hasConcept C203014093 @default.
• W3166794562 hasConcept C2776107976 @default.
• W3166794562 hasConcept C2776256026 @default.
• W3166794562 hasConcept C2777701055 @default.
• W3166794562 hasConcept C2779282312 @default.
• W3166794562 hasConcept C2779438470 @default.
• W3166794562 hasConcept C2781182431 @default.
• W3166794562 hasConcept C2781187634 @default.
• W3166794562 hasConcept C2908647359 @default.
• W3166794562 hasConcept C501734568 @default.
• W3166794562 hasConcept C502942594 @default.
• W3166794562 hasConcept C526805850 @default.
• W3166794562 hasConcept C55493867 @default.
• W3166794562 hasConcept C71924100 @default.
• W3166794562 hasConcept C86803240 @default.
• W3166794562 hasConcept C8891405 @default.
• W3166794562 hasConcept C99454951 @default.
• W3166794562 hasConceptScore W3166794562C104317684 @default.
• W3166794562 hasConceptScore W3166794562C121608353 @default.
• W3166794562 hasConceptScore W3166794562C126322002 @default.
• W3166794562 hasConceptScore W3166794562C143998085 @default.
• W3166794562 hasConceptScore W3166794562C203014093 @default.
• W3166794562 hasConceptScore W3166794562C2776107976 @default.
• W3166794562 hasConceptScore W3166794562C2776256026 @default.
• W3166794562 hasConceptScore W3166794562C2777701055 @default.
• W3166794562 hasConceptScore W3166794562C2779282312 @default.
• W3166794562 hasConceptScore W3166794562C2779438470 @default.
• W3166794562 hasConceptScore W3166794562C2781182431 @default.
• W3166794562 hasConceptScore W3166794562C2781187634 @default.
• W3166794562 hasConceptScore W3166794562C2908647359 @default.
• W3166794562 hasConceptScore W3166794562C501734568 @default.
• W3166794562 hasConceptScore W3166794562C502942594 @default.

• next